3,517 Shares in Danaher Corporation $DHR Bought by Wellspring Financial Advisors LLC

Wellspring Financial Advisors LLC bought a new position in Danaher Corporation (NYSE:DHR) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 3,517 shares of the conglomerate’s stock, valued at approximately $805,000.

Other hedge funds have also modified their holdings of the company. Elevated Capital Advisors LLC acquired a new position in shares of Danaher in the 4th quarter worth $26,000. Hilton Head Capital Partners LLC purchased a new position in shares of Danaher during the fourth quarter valued at $27,000. JPL Wealth Management LLC purchased a new position in shares of Danaher during the third quarter valued at $25,000. WFA of San Diego LLC purchased a new position in shares of Danaher during the second quarter valued at $26,000. Finally, ANTIPODES PARTNERS Ltd purchased a new position in shares of Danaher during the third quarter valued at $27,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of NYSE DHR opened at $183.88 on Thursday. The business’s 50-day moving average price is $181.33 and its two-hundred day moving average price is $205.28. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a market capitalization of $130.14 billion, a P/E ratio of 35.57, a price-to-earnings-growth ratio of 2.52 and a beta of 0.81.

Danaher (NYSE:DHR) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the company posted $1.88 earnings per share. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. Analysts anticipate that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s payout ratio is 30.95%.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. Evercore lifted their price target on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a report on Tuesday, April 21st. DZ Bank assumed coverage on Danaher in a report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target on the stock. Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. The Goldman Sachs Group lowered their price target on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Monday, April 13th. Finally, Jefferies Financial Group reiterated a “buy” rating and set a $245.00 price target on shares of Danaher in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $235.14.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.